Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma
- PMID: 27694925
- PMCID: PMC6005364
- DOI: 10.1038/leu.2016.253
Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma
Abstract
Hyperhaploid clones (24-34 chromosomes) were identified in 33 patients with multiple myeloma (MM), demonstrating a novel numerical cytogenetic subgroup. Strikingly, all hyperhaploid karyotypes were found to harbor monosomy 17p, the single most important risk stratification lesion in MM. A catastrophic loss of nearly a haploid set of chromosomes results in disomies of chromosomes 3, 5, 7, 9, 11, 15, 18, 19 and 21, the same basic set of odd-numbered chromosomes found in trisomy in hyperdiploid myeloma. All other autosomes are found in monosomy, resulting in additional clinically relevant monosomies of 1p, 6q, 13q and 16q. Hypotriploid subclones (58-68 chromosomes) were also identified in 11 of the 33 patients and represent a duplication of the hyperhaploid clone. Analysis of clones utilizing interphase fluorescence in situ hybridization (iFISH), metaphase FISH and spectral karyotyping identified either monosomy 17 or del17p in all patients. Amplification of 1q21 was identified in eight patients, demonstrating an additional high-risk marker. Importantly, our findings indicate that current iFISH strategies may be uninformative or ambiguous in the detection of these clones, suggesting this patient subgroup maybe underreported. Overall survival for patients with hyperhaploid clones was poor, with a 5-year survival rate of 23.1%. These findings identify a distinct numerical subgroup with cytogenetically defined high-risk disease.
Conflict of interest statement
Conflict of Interest: The authors declare no conflict of interest.
Figures




References
-
- Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012;12(5):335–48. - PubMed
-
- Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C Groupe Français de Cytogénétique Hématologique. Hypodiploidy is a major prognostic factor in multiple myeloma. Blood. 2001 Oct 1;98(7):2229–38. - PubMed
-
- Shaffer LG, McGowan-Jordan J, Schmid M, editors. ISCN (2013) An International System for Human Cytogenetic Nomenclature. S.Kager; Basel: 2013.
-
- Mandahl N, Johansson B, Mertens F, Mitelman F. Disease-Associated patterns of Disomic Chromosomes in Hyperhaploid Neoplasms. Genes Chrom Cancer. 2012;51:536–544. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical